Biapenem
![]() |
|
Systematic (IUPAC) name | |
---|---|
(4R,5S,6S)-3-(6,7-dihydro-5H- pyrazolo[1,2-a][1,2,4]triazol-8- ium-6-ylsulfanyl)- 6-(1-hydroxyethyl)- 4-methyl-7-oxo-1-azabicyclo[3.2.0]hept-2- ene-2-carboxylate
|
|
Clinical data | |
AHFS/Drugs.com | International Drug Names |
Legal status |
|
Routes of administration |
IV |
Identifiers | |
CAS Number | 120410-24-4 ![]() |
ATC code | J01DH05 (WHO) |
PubChem | CID: 71339 |
ChemSpider | 64442 ![]() |
UNII | YR5U3L9ZH1 ![]() |
ChEBI | CHEBI:3089 ![]() |
ChEMBL | CHEMBL285347 ![]() |
Chemical data | |
Formula | C15H18N4O4S |
Molecular mass | 350.39 g/mol |
|
|
|
|
(verify) |
Biapenem (INN) is a carbapenem antibiotic. It has in vitro activity against anaerobes.[1] 1-β-methyl-carbapenem antibiotic. Approved in Japan in 2001.
Synthesis
The tin enolate of N-propionyl (4R)-4-Methyl-1,3-thiazolidine-2-thione is prepared by reaction with tin triflate; the chiral heterocyclic ring determines the stereochemical outcome of the next step. Thus condensation of the enolate with the azetidone (3)[4] gives the product from the formal dispalcement of the acetoxy group in the azetidone. This net retention of configuration probably results from the circumstance that the reaction proceeds via the elimination product of 3 or a carbocation equivalent. Treatment of the product 4 with the magnesium salt from the half-ester of malonic acid leads to displacement of the thiazolidine amide by the malonate to give the intermediate acylation product. Hydrochloric acid causes the tricarbonyl compound to decarboxylate; the silyl ether of the side chain is cleaved in the process to give 5. Reaction of the beta-keto ester with 4-n-dodecylphenylsulfonyl azide[5][6] leads to the transfer of a diazo grouping and formation of the diazoketone (6). Treatment with a rhodium salt results in loss of nitrogen and formation of the corresponding carbene. The very reactive function then inserts in the adjacent N-H bond, forming the fused five-membered ring (7). Diphenyl chlorophosphate then converts the beta-keto ester in 7 to the relatively stable enol phosphate derivative (8).
A key reaction in the synthesis of imipenem consists of displacement of the enol phosphate from an intermediate such as 8 by sulfur. In the present case, reaction of 8 with the protected Pyrazolidine thiol leads to the thioenol ether (9), probably by an addition-elimination sequence. Hydrogenation of the product over palladium leads to reductive cleavage of the protection groups and formation of the amino acid (10). Treatment of that product with Ethyl formimidate leads to conversion of the hydrazine function to a 1,2,4-triazolium ring. The crude product is then passed over an ion-exchange column to convert it to a betaine.
References
<templatestyles src="Reflist/styles.css" />
Cite error: Invalid <references>
tag; parameter "group" is allowed only.
<references />
, or <references group="..." />
External links
- (Japanese) Omegacin
<templatestyles src="Asbox/styles.css"></templatestyles>
- ↑ Lua error in package.lua at line 80: module 'strict' not found.
- ↑ T. Kumagai et al., EP 289801; eidem, U.S. Patent 4,990,613 (1988, 1991 both to Lederle).
- ↑ Lua error in package.lua at line 80: module 'strict' not found.
- ↑ Lua error in package.lua at line 80: module 'strict' not found.
- ↑ Lua error in package.lua at line 80: module 'strict' not found.
- ↑ Lua error in package.lua at line 80: module 'strict' not found.
- Pages with reference errors
- Drugs with non-standard legal status
- Chemical articles having calculated molecular weight overwritten
- Infobox drug articles without a structure image
- Chemical pages without DrugBank identifier
- Articles without KEGG source
- Articles with Japanese-language external links
- Carbapenem antibiotics
- Antibiotic stubs